- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01139086
Role of Endothelial Function, Muscular Fitness and Metabolism in Functional Activity in Patients With Chronic Heart Failure (CHF)
Role of Endothelial Function, Muscular Fitness and Metabolism in Functional Activity in Patients With Chronic Heart Failure
Shortness of breath, fatigue, and exercise intolerance are clinical symptoms of chronic heart failure (CHF). Recent studies suggested that peripheral impairment was the major cause of clinical symptoms, and mechanism may be related to neuroendocrine impairment and vascular smooth muscle dysfunction. It results in increased peripheral resistance that may influence limb blood flow, muscle fitness and activities of daily.The purposes of this study are
- to compare muscular strength, endurance, and perfusion of quadriceps between CHF patients and healthy controls by isokinetic test and near-infrared spectroscopy (NIRS) and difference in activities of daily living
- to compare endothelium function between CHF patients and healthy control subjects
- the relationship between endothelium function, muscular strength, endurance, perfusion, and metabolism of quadriceps.
Study Overview
Status
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Taipei City, Taiwan, 100
- Recruiting
- National Taiwan University Hospital
-
Contact:
- Ying-Tai Wu, Ph. D
- Phone Number: 886-2-33668129
- Email: ytw@ntu.edu.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 40-75 years
- Chronic heart failure: ejection fraction<40% and at stable condition
- Coronary Disease and dilated cardiomyopathy without heart failure
- Control group without diagnosis of any heart disease
Exclusion Criteria:
- Clinical diagnosis of neuromusculoskeletal , pulmonary, or other systemic diseases that may affect the testing of the study
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Cardiovascular disease
Diagnosis of cardiomyopathy or ischemic heart disease without heart failure
|
|
Chronic heart failure
Diagnosis of cardiomyopathy or ischemic heart disease LVEF <40%
|
|
Control
Age and body built matched with chronic heart failure group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
muscle strength and endurance
Time Frame: baseline
|
Measured by biodex
|
baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
skeletal muscle oxygenation response
Time Frame: baseline
|
Measured by near-infrared spectroscopy
|
baseline
|
|
Walking distance in 6-minute walking test
Time Frame: baseline
|
walking distance (m)
|
baseline
|
|
laser Doppler flowmetry combine iontophoresis
Time Frame: baseline
|
To measure the blood flux (PU) response to Ach (endothelial-dependent agent) and SNP (endothelial-independent agent)
|
baseline
|
|
sit-to-stand test
Time Frame: baseline
|
Measured times in 1 minute
|
baseline
|
|
questionnaire (functional activity and quality of life)
Time Frame: baseline
|
baseline
|
|
|
Analysis of venous blood sample
Time Frame: baseline
|
By standard venipuncture
|
baseline
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201003050R
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Disease
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
OPCI Core Laboratories LLCNot yet recruitingCoronary Artery Disease (CAD) | Coronary Calcification | Coronary Calcified Disease | Coronary Calcified NodulesUnited States
-
University of GalwayNot yet recruitingMyocardial Ischemia | Percutaneous Coronary Intervention | Chronic Coronary Syndrome | Coronary Computed Tomography Angiography | Acute Coronary Syndromes (ACS) | Coronary Arteries Disease
-
Shunmei MedicalNot yet recruitingCalcified Coronary Artery Disease | Coronary Arterial DiseasePoland, France, Spain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Percutaneous Coronary Intervention | Coronary Stenosis | Coronary Restenosis | Coronary Artery Disease Progression | Coronary Stent Occlusion | Myocardial Revascularization
-
Kaohsiung Veterans General Hospital.CompletedChronic Coronary Syndrome; Coronary Artery Disease; Percutaneous Coronary InterventionTaiwan
-
Olivier F. BertrandRecruitingBifurcation Coronary Disease | Restenosis, Coronary | Coronary Arterial Disease (CAD)Canada
-
Ceric SàrlEuropean Cardiovascular Research Center; Philips Medical SystemsNot yet recruitingStable Coronary Artery Disease | Acute Coronary Syndromes
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaTerminatedCoronary Stenosis | Coronary Artery Bypass Grafting | Coronary Artery Disease Progression | Percutaneous Coronary RevascularizationSouth Korea
-
SUK MIN SEODaewoong Pharmaceutical Co. LTD.RecruitingCoronary Artery Disease (CAD) | Acute Coronary Syndromes (ACS)South Korea